Today, we approved a one-time gene therapy product for treatment as an adjunct to nutritional management of patients 8 years of age and older with glycogen stor

Today, we approved a one-time gene therapy product for treatment as an adjunct to nutritional management of patients 8 years of age and older with glycogen storage disease type Ia (GSDIa). This is the first therapy approved for this condition in patients 8 and older.